| 摘要 |
<p>Based on anti-ICAM3 antibody that is obtained by immunizing a mouse with BaF3 cells artificially overexpressing ICAM3, a chimeric antibody, which exerts cytotoxic actions, including both of a growth inhibitory activity and an ADCC activity, and a tumor regression activity in vivo on a blood cancer cell line, can be successfully prepared.</p> |
